Company intelligence
BioWave Corporation
BioWave is a non-opioid, FDA cleared, professional athlete-proven, and trusted pain relief technology.
About BioWave Corporation
BioWave is a Medtech company redefining pain management through our innovative, non-invasive technology that delivers powerful relief without drugs or surgery. We offer a range of products designed to meet the unique needs of different markets, delivering effective, customized pain relief solutions where they’re needed most. Our technology is backed by clinical evidence and real-world results, helping patients reduce pain, restore function, and reclaim their lives. Trusted by healthcare professionals, athletes, veterans, and individuals alike, BioWave targets pain at its source to provide long-lasting results. The information, including but not limited to, text, graphics, images and other material contained herein are for informational purposes only. It is not intended to be a substitute for medical billing advice, professional medical advice, diagnosis, or treatment. Any information contained herein are subject to a full examination of the medical studies, FDA filings and medical literature that underlie the claims. Learn more at BioWave.com. https://biowave.com/terms-of-use/
Verified activity
Signals from BioWave Corporation
3 published signals
Presence & Recognition
BioWave Corporation hosted a live conversation on September 15 featuring Jamal Cort, DPT, ATC, CES, PES, Head Athletic Trainer, and Director of Rehabilitation for the Utah Jazz about treating pain associated with basketball injuries and strategies for rehabilitation, recovery, and return to play.
Reported by BioWave Corporation
Presence & Recognition
BioWave Corporation is attending the CAALA 2026 event in Fontainebleau Las Vegas from September 3 to 6, 2026, at Booth 1029 to showcase BioWavePENS neuromodulation and personal injury pain management solutions.
Reported by BioWave Corporation
People
BioWave Corporation is hiring a new Quality Systems Associate in Westport, Connecticut.
Reported by BioWave Corporation